Cannabinoid Receptor 2 (CNR2) (C-Term) Peptide
Quick Overview for Cannabinoid Receptor 2 (CNR2) (C-Term) Peptide (ABIN8096119)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- CNR2 Peptide - C-terminal region
-
Sequence
- MVNPVIYALR SGEIRSSAHH CLAHWKKCVR GLGSEAKEEA PRSSVTETEA
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CNR2 Antibody (ARP63486_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CNR2 (Cannabinoid Receptor 2 (CNR2))
-
Background
-
Background Information: The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors.
Alternative Symbols: CB2, CX5
-
Molecular Weight
- 40kDa
-
Gene ID
- 1269
-
NCBI Accession
- NP_001832
-
UniProt
- P34972
Target
-